h-header

news

News dal mondo

20

Apr

Pharmaceutical reshoring: a strategic necessity

More than a year into the COVID-19 crisis, the novel coronavirus continues to disrupt our societies, including how the pharmaceutical industry operates; Andrew Badrot, CEO of C2 PHARMA, discusses the ongoing ramifications of the pandemic...[Manufacturing Chemist]

06

Mag

EDQM - New policy for the development of monographs on medicinal products containing chemically defined active substance salts or bases/acids

At its 169th session (March 2021), the European Pharmacopoeia (Ph. Eur.) Commission approved a new...

05

Mag

EU Draft report on a pharmaceutical strategy for Europe

Draft report on a pharmaceutical strategy for Europe [2021/2013(INI) – Rev. 26 aprile...

slider-banner

h-footer